Overview

hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis

Status:
NOT_YET_RECRUITING
Trial end date:
2028-04-04
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of hUC-MSCs-Exos in the treatment of ulcerative colitis.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Shanghai East Hospital